Studies on the polymorphism in the genome of polyomavirus BK: implications for cell tropism and the pathology
This project wants to isolate and characterise naturally occurring BKV variants. Knowledge on the naturally circulating BKV strains in patients may help us to define the possible implications of genome diversity with respect to cell tropism and pathogenicity, and may enable us to design successful therapeutic strategies.
Project leader(s) Ugo Moens and Christine Hanssen Rinaldo
Co-workers / Project staff
Gunn-Hege Olsen, Berit Tømmerås
Main Objects:
This project wants to isolate and characterise naturally occurring BKV variants. Knowledge on the naturally circulating BKV strains in patients may help us to define the possible implications of genome diversity with respect to cell tropism and pathogenicity, and may enable us to design successful therapeutic strategies.
Project outline
The human polyomavirus BK (BKV) was originally isolated from the urine of a renal allograft recipient who developed ureteric stenosis and was named after the initials of this patient. Serological surveys have shown that BKV is distributed worldwide and has a high incidence among humans. Primary infection occurs predominantly during childhood and appears to be asymptomatic, although few cases of BKV-induced mild respiratory or urinary tract diseases, pyrexia, fatal disseminated infection, and hemorrhagic cystitis have been reported in immunosuppressed patients. After primary infection, BKV establishes a harmless latent infection in healthy individuals. BKV is a small non-enveloped DNA virus that belongs to the family of Polyomaviridae. Its genome can be divided in three functional domains: (1) the early region that encodes regulatory proteins, including the large T-antigen and small t-antigen; (2) the late region that encompasses the genetic information for the capsid proteins VP1, VP2, VP3, and the agnoprotein; and (3) the non-coding control region (NCCR) that spans the origin of replication (O-block, 142 base-pairs) and sequences involved in transcriptional regulation of both the early and the late genes. The transcriptional control region of the proposed archetypal BK strain WW has been arbitrarily divided into 4 transcription factor binding sequence blocks, called P (68 base-pairs), Q (39 base-pairs), R (63 base-pairs), and S (63 base-pairs) as depicted in Figure 1. The genomes of naturally occurring BKV strains display high sequence diversity, especially in the NCCR, but also in the other regions. Our group studies this genomic polymorphism in different patient groups. We also examine the functionality of putative transcription factor binding sites in the different NCCRs of naturally occurring BKV strains.
Collaborators
-Dr. Marijke Van Ghelue, Department of medical Genetics, University Hospital, Tromsø